BioArctic AB Class B BRCTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $17.25
- Day Range
- $17.75–17.84
- 52-Week Range
- $16.77–30.03
- Bid/Ask
- $11.15 / $23.80
- Market Cap
- $1.57 Bil
- Volume/Avg
- 405 / 432
Key Statistics
- Price/Earnings (Normalized)
- 73.41
- Price/Sales
- 27.10
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 100
- Website
- https://www.bioarctic.se
Comparables
Valuation
|
Metric
|
BRCTF
|
CALTX
|
HNSA
|
|---|---|---|---|
Price/Earnings (Normalized) | 73.41 | — | — |
Price/Book Value | 14.97 | 16.62 | — |
Price/Sales | 27.10 | 4.61 | 8.66 |
Price/Cash Flow | 56.30 | — | — |
Price/Earnings
BRCTF
CALTX
HNSA
Financial Strength
|
Metric
|
BRCTF
|
CALTX
|
HNSA
|
|---|---|---|---|
Quick Ratio | 9.15 | 2.85 | 2.57 |
Current Ratio | 9.22 | 3.13 | 2.66 |
Interest Coverage | 739.59 | −5.64 | −7.14 |
Quick Ratio
BRCTF
CALTX
HNSA
Profitability
|
Metric
|
BRCTF
|
CALTX
|
HNSA
|
|---|---|---|---|
Return on Assets (Normalized) | 22.04% | −24.68% | −71.82% |
Return on Equity (Normalized) | 24.17% | −89.92% | — |
Return on Invested Capital (Normalized) | 21.25% | −31.14% | −85.22% |
Return on Assets
BRCTF
CALTX
HNSA
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Tzzyxpkswp | Hrjy | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Hnkmrxw | Rtrkts | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Rglcytsd | Ndffyk | $97.8 Bil | |
MRNA
| Moderna Inc | Hmhlrtq | Hfjb | $41.3 Bil | |
ARGX
| argenx SE ADR | Ccklntkc | Lfp | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Bwgfqxmq | Nsf | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zdntlgtf | Jkyrbt | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jgwmhpq | Zbvyv | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Ttdtzyxll | Gcbxrrc | $12.5 Bil | |
INCY
| Incyte Corp | Sbpqqqtk | Txczxm | $11.6 Bil |